Fox Business - The Power to Prosper
Search Site

Wednesday, April 7, 2010 as of 11:14 AM ET

Eli Lilly

More Headlines »« Less Headlines
Eli Lilly

Eli Lilly (July 8, 1838 – June 6, 1898) was an American soldier, pharmaceutical chemist, industrialist, entrepreneur, and founder of the Eli Lilly and Company pharmaceutical corporation.

Read More at Wikipedia ›

Related Topics

  1. John Lechleiter
  2. Pfizer
  3. Novartis
  4. Food And Drug Administration
  5. Merck
  6. Amylin Pharmaceuticals
Get updates on Eli Lilly
Lilly Upbeat on Type-2 Diabetes Drug

Eli Lilly (NYSE:LLY) and partner Boehringer Ingelheim Pharmaceuticals announced on Thursday positive results for a late-stage study of an experimental treatment for type 2 diabetes in black and African American adult patients.

The once-daily tablet, marketed as Tradjenta, showed significant hemoglobin reduction of 0.88% compared with 0.24% in the placebo group at 24 weeks in patients whose blood sugar had not previously been adequately controlled, Lilly said.The study proved the efficacy and safety profile of the drug, known experimentally as linagliptin.The drug is intended to be used with diet and exercise to lower blood sugar in adults with type 2 diabetes mellitus. The treatment, unlike some of its competitors, doesn't require adjustments to dosage regardless of declining renal function or hepatic impairment, Lilly said. The published trial marks the first of so-called DPP-4 inhibitors conducted specifically on black and African American adult type-2 patients."In the U.S., African A...

Read More ›

  1. Markets Up, Waiting on the Fed

    FBN’s Nicole Petallides with a look at what’s moving the markets this afternoon.

  2. Lilly 1Q Profit Narrows, But Beats on Cymbalta Demand

    Eli Lilly (NYSE:LLY) revealed on Wednesday a 25% drop in first-quarter net income, excluding one-time items, as sales of schizophrenia drug Zyprexa plunged after los...

  3. Sun Pharmaceutical Gets US OK To Sell Generic Version Of Zyprexa

    Sun Pharmaceutical Industries Ltd. (524715.BY) said Tuesday it received approval from the U.S. Food and Drug Administration to make and sell a generic version of Eli...

  4. Drug Executives Tout R&D Spending As Industry Hits Patent Cliff

    Drug-industry executives touted on Thursday the investments they are making to discover new products in the face of a so-called patent cliff that will dramatically c...

  5. Is High U.S. Spending on Cancer Care 'Worth it'?

    With the United States spending more on healthcare than any other country - $2.5 trillion, or just over $8,000 per capita, in 2009 - the question has long been, is i...

  6. Kodak Wants to Use Bonuses to Retain Workers

    FBN’s Diane Macedo with news that Eastman Kodak is seeking permission to use bonuses to retain workers while the company reorders under Chapter 11.

  7. Amylin: EU Approves Diabetes Treatment Byetta With Basal Insulin

    DOW JONES NEWSWIRESAmylin Pharmaceuticals Inc. (AMLN) and Eli Lilly & Co. (LLY) said the European Commission approved its type 2 diabetes treatment Byetta as an add-...

  8. Drug Industry's Lifeblood Evolves as Patents Expire

    The world’s largest producers of new drugs and medicines are facing an unprecedented time in their history as a record number of patents expire and generic drugs swo...

  9. Sun Pharmaceutical Gets US OK To Sell Generic Of Schizophrenia Drug

    Sun Pharmaceutical Industries Ltd. (524715.BY) said Wednesday it has received approval from the U.S. Food and Drug Administration to make and sell a generic version ...

  10. Lilly Faces Payment Delays From Health Systems In Italy, Spain

    Drug maker Eli Lilly & Co. (LLY) said it has experienced delays in payments for its products from national health systems in Spain and Italy--the latest example of p...

  11. Eli Lilly CEO on Drug Innovation, Corporate Taxes

    Eli Lilly CEO John Lechleiter on new drugs in the company’s pipeline and Obama’s corporate tax proposal.

  12. Haul Of Suspected Fake Sex Drugs Seized In UK

    A haul of suspected fake sex drugs with an estimated value of GBP140,000 were seized Wednesday by U.K. authorities following raids at three London homes.Around 28,00...

  1. Eli Lilly : Diabetes Drug Meets Cardiovascular Goals

    Eli Lilly & Co. (LLY) said dulaglutide, an investigational treatment for Type 2 diabetes, met a primary endpoint for blood pressure and heart rate effects in a 16-we...

  2. Dr Reddy's Jan-March Net Grows 2.7%; Misses View On One-Time Charge

    Dr. Reddy's Laboratories Ltd. (500124.BY) Friday disappointed investors with a slim 2.7% rise in its fourth-quarter net profit, but this was due mainly to a one-time...

  3. Drug Makers Refute India Allegations Of Regulatory Irregularities

    Multinational and Indian pharmaceutical companies Thursday refuted the findings of a probe conducted by Indian lawmakers which said they violated rules governing app...

  4. GlaxoSmithKline: Complied With Indian Rules In Getting Heart, Lung Drug Approved

    GlaxoSmithKline PLC (GSK) said Thursday the company was granted a waiver on conducting clinical trials in India for ambrisentan, its drug to treat pulmonary arterial...

  5. Teva 1Q Profit Up 13% On Branded, Generic Drug Sales

    Teva Pharmaceutical Industries Ltd. (TEVA) said Wednesday its first-quarter profit rose 13%, as sales growth for branded and generic drugs in the U.S. and emerging m...

  6. Abbott To Pay $1.6 Billion To Settle Depakote Marketing Probes

    Abbott Laboratories (ABT) agreed to pay $1.6 billion and plead guilty to violating a federal drug law to resolve allegations that the company improperly promoted ant...

  7. FDA Approves Stendra For Erectile Dysfunction

    The Food and Drug Administration Friday approved a new drug from Vivus Inc. (VVUS) to treat erectile dysfunction.The approval of the drug, Stendra, is the first prod...

‹ Prev12345…Next ›
Freebase CC-BY
Source: Eli Lilly on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL